FNY Investment Advisers’s Estrella Immunopharma ESLA Stock Holding History

FNY Investment Advisers’s Portfolio ESLA Stock Details ESLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,000	Closed	-$54K	–	642
2023 Q2	$54K	Buy	+5,000	New	+$53.9K	0.07%	153

Other funds holding ESLA

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

FNY Investment Advisers's ESLA Position: Q3 2023 in Review

FNY Investment Advisers sold out of Estrella Immunopharma (ESLA) in Q3 2023, closing a stake of 5,000 shares — an estimated $54K sold.

FNY Investment Advisers first reported a position in ESLA in Q2 2023 and held it in 1 quarter. The position peaked at $54K in Q2 2023. 3 funds tracked by Wall St. Rank hold ESLA as of Q3 2023.

FNY Investment Advisers reported no remaining Estrella Immunopharma position as of Q3 2023 after selling out during the quarter.
FNY Investment Advisers sold 5,000 Estrella Immunopharma shares in Q3 2023, an estimated $54K.
FNY Investment Advisers first reported a position in Estrella Immunopharma in Q2 2023 and held it in 1 quarter.
FNY Investment Advisers's Estrella Immunopharma position peaked at $54K in Q2 2023.
3 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q3 2023.

Based on FNY Investment Advisers's 13F filing for Q3 2023, filed 10 Oct 2023.